LifeScience
Illumina collaborates with National Cancer Center Japan to address a leading cause of death in Asia
Illumina, Inc. (NASDAQ: ILMN) and the National Cancer Center Japan have announced an international joint research project that will use Illumina's hig...
January 25, 2022 | News
Harbour Group's SpotSee Acquires the Assets of Biosynergy
Biosynergy manufactures and distributes temperature indicators used in the life sciences market, primarily in monitoring temperature on blood bags. M...
January 25, 2022 | News
Australia (TGA) Grants Provisional Registration for Novavax COVID-19 Vaccine
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...
January 20, 2022 | News
Eppendorf & Science Prize for Neurobiology 2022 Call for Entries!
This annual international research prize of US$25,000 is awarded to young scientists for their outstanding contributions to neurobiological research based ...
January 19, 2022 | News
Seegene Unveils Blueprint for the Future of Molecular Diagnostics
Along with three solutions, he also introduced the company's automated, AI-enabled platform with a standard development tool that will empower users to eas...
January 13, 2022 | News
Illumina collaborates with Nashville Biosciences to accelerate medicines development
Illumina, Inc. (NASDAQ: ILMN) and Nashville Biosciences, LLC, a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC)...
January 11, 2022 | News
Azenta Life Sciences Expands Fleet of PacBio HiFi Sequencing Systems
PacBio (Nasdaq: PACB) today announced an expansion of its extensive suite of HiFi applications with Azenta Life Sciences, formerly GENEWIZ. The deal will i...
January 07, 2022 | News
Imvaq Therapeutics Signs a Service and Commercial Product License to Use ProBioGen’s AGE1.CR® Vaccine Manufacturing Platform
Under this agreement, ProBioGen develops a scalable process and granted Imvaq® a license to use ProBioGen's AGE1.CR.pIX cell line for the man...
January 07, 2022 | News
Illumina Enters Co-Development Partnership with SomaLogic
Illumina, Inc. (NASDAQ: ILMN) today announced it has entered into a definitive co-development agreement with SomaLogic to bring the SomaScan® Prot...
January 06, 2022 | News
GC Cell seeks to expand global availability of Immuncell-LC® for liver cancer
Rivaara Immune to lead development and commercialization in India GC Cell (KOSDAQ:144510) and Rivaara Immune Private Limited today announced that they hav...
January 05, 2022 | News
Alamar Biosciences partners with Abcam to drive understanding of the human proteome
Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of cancer and othe...
January 05, 2022 | News
Ionis and AstraZeneca close deal to develop and commercialize eplontersen
Ionis' investigational antisense medicine for the treatment of transthyretin amyloidosis (ATTR), following expiration of the waiting period under the Hart-...
January 03, 2022 | News
Covovax Receive EUA for COVID-19 Vaccine in India
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...
December 29, 2021 | News
Theramex announces an agreement with Enzene Biosciences Limited for the development and commercialisation of Tocilizumab
Theramex, a leading global speciality pharmaceutical company dedicated to women’s health, has entered into an agreement with Enzene Biosciences Limit...
December 24, 2021 | News
Most Read
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
- ACG Leads the Charge in Vegan Capsules: Innovation, Certification, and the Future of Sustainable Pharma
- ORA’s Hybrid Model Reshapes Obesity Care: Dr. Ben Ng on Bridging Telehealth and In-Person Treatment
- Heather Hargett on How Merck’s HUB Organoids Acquisition is Reshaping 3D Cell Culture and Drug Development
- Health2Sync's Vision for Diabetes Care: Transforming Outcomes Through Technology and Partnerships
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
